What Explains the Benefits of ARNI Therapy in Heart Failure?
- PMID: 30898203
- DOI: 10.1016/j.jacc.2019.01.019
What Explains the Benefits of ARNI Therapy in Heart Failure?
Erratum in
-
Correction.J Am Coll Cardiol. 2019 Jun 4;73(21):2789. doi: 10.1016/j.jacc.2019.03.461. Epub 2019 Mar 22. J Am Coll Cardiol. 2019. PMID: 30910539 No abstract available.
Keywords: biomarkers; heart failure; natriuretic peptide; neprilysin.
Comment on
-
B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan: The PARADIGM-HF Trial.J Am Coll Cardiol. 2019 Mar 26;73(11):1264-1272. doi: 10.1016/j.jacc.2019.01.018. Epub 2019 Mar 4. J Am Coll Cardiol. 2019. PMID: 30846338 Free PMC article. Clinical Trial.
-
Effect of Neprilysin Inhibition on Various Natriuretic Peptide Assays.J Am Coll Cardiol. 2019 Mar 26;73(11):1273-1284. doi: 10.1016/j.jacc.2018.12.063. J Am Coll Cardiol. 2019. PMID: 30898202
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
